These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 15862821)

  • 21. Vesicular trafficking of tyrosine kinase receptors and associated proteins in the regulation of signaling and vascular function.
    Mukherjee S; Tessema M; Wandinger-Ness A
    Circ Res; 2006 Mar; 98(6):743-56. PubMed ID: 16574915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Vascular protection with estrogen. In-vitro and in-vivo effects--mechanisms and clinical implication].
    Barton M; Wright E; Dai-Do D; Yang Z; Espinosa E; Arnet U; Lüscher TF
    Praxis (Bern 1994); 1997 Jan; 86(5):129-37. PubMed ID: 9064730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogens in vascular biology and disease: where do we stand today?
    Arnal JF; Scarabin PY; Trémollières F; Laurell H; Gourdy P
    Curr Opin Lipidol; 2007 Oct; 18(5):554-60. PubMed ID: 17885427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rationale for using nitric oxide donor therapy for prevention of bone loss and treatment of osteoporosis in humans.
    Wimalawansa SJ
    Ann N Y Acad Sci; 2007 Nov; 1117():283-97. PubMed ID: 18056048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating cardiovascular disease risk factors and signaling in endothelial cell caveolae.
    Mineo C; Shaul PW
    Cardiovasc Res; 2006 Apr; 70(1):31-41. PubMed ID: 16540099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular effects of estrogens: rapid actions, novel mechanisms, and potential therapeutic implications.
    Barton M
    Zhongguo Yao Li Xue Bao; 1999 Aug; 20(8):682-90. PubMed ID: 10678098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endothelial nitric oxide synthase activation by tumor necrosis factor alpha through neutral sphingomyelinase 2, sphingosine kinase 1, and sphingosine 1 phosphate receptors: a novel pathway relevant to the pathophysiology of endothelium.
    De Palma C; Meacci E; Perrotta C; Bruni P; Clementi E
    Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):99-105. PubMed ID: 16269668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebrovascular effects of oestrogen: multiplicity of action.
    Duckles SP; Krause DN
    Clin Exp Pharmacol Physiol; 2007 Aug; 34(8):801-8. PubMed ID: 17600562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen's actions transcend a sole reproductory function in cell signaling.
    Mantione KJ
    Med Sci Monit; 2008 Feb; 14(2):SC1-3. PubMed ID: 18227774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Agonist-stimulated endothelial nitric oxide synthase activation and vascular relaxation. Role of eNOS phosphorylation at Tyr83.
    Fulton D; Ruan L; Sood SG; Li C; Zhang Q; Venema RC
    Circ Res; 2008 Feb; 102(4):497-504. PubMed ID: 18096817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma membrane localization and function of the estrogen receptor alpha variant (ER46) in human endothelial cells.
    Li L; Haynes MP; Bender JR
    Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4807-12. PubMed ID: 12682286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exogenous nitric oxide regulates activity and synthesis of vascular endothelial nitric oxide synthase.
    Schmidt A; Bilgasem S; Lorkowski S; Vischer P; Völker W; Breithardt G; Siegel G; Buddecke E
    Eur J Clin Invest; 2008 Jul; 38(7):476-85. PubMed ID: 18578689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen modulation of endothelial nitric oxide synthase.
    Chambliss KL; Shaul PW
    Endocr Rev; 2002 Oct; 23(5):665-86. PubMed ID: 12372846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of endothelial nitric oxide synthase by dietary isoflavones: role of NO in Nrf2-mediated antioxidant gene expression.
    Mann GE; Rowlands DJ; Li FY; de Winter P; Siow RC
    Cardiovasc Res; 2007 Jul; 75(2):261-74. PubMed ID: 17498676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 17beta-estradiol antagonizes the down-regulation of endothelial nitric-oxide synthase and GTP cyclohydrolase I by high glucose: relevance to postmenopausal diabetic cardiovascular disease.
    Miyazaki-Akita A; Hayashi T; Ding QF; Shiraishi H; Nomura T; Hattori Y; Iguchi A
    J Pharmacol Exp Ther; 2007 Feb; 320(2):591-8. PubMed ID: 17082313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of action of estrogen receptors in vascular cells: relevance for menopause and aging.
    Simoncini T
    Climacteric; 2009; 12 Suppl 1():6-11. PubMed ID: 19811233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integration of steroid hormone initiated membrane action to genomic function in the brain.
    Vasudevan N; Kow LM; Pfaff D
    Steroids; 2005; 70(5-7):388-96. PubMed ID: 15862822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stimulated HSP90 binding to eNOS and activation of the PI3-Akt pathway contribute to globular adiponectin-induced NO production: vasorelaxation in response to globular adiponectin.
    Xi W; Satoh H; Kase H; Suzuki K; Hattori Y
    Biochem Biophys Res Commun; 2005 Jun; 332(1):200-5. PubMed ID: 15896318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Raloxifene, tamoxifen and vascular tone.
    Leung FP; Tsang SY; Wong CM; Yung LM; Chan YC; Leung HS; Yao X; Huang Y
    Clin Exp Pharmacol Physiol; 2007 Aug; 34(8):809-13. PubMed ID: 17600563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Grape juice causes endothelium-dependent relaxation via a redox-sensitive Src- and Akt-dependent activation of eNOS.
    Anselm E; Chataigneau M; Ndiaye M; Chataigneau T; Schini-Kerth VB
    Cardiovasc Res; 2007 Jan; 73(2):404-13. PubMed ID: 16962569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.